Cuál es el precio por Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)

Precio por Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) es de$0.17

Cuál es la capitalización de mercado por Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)

Capitalización de mercado por Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) es $5.65M

Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) Ratio P/E

Holdco Nuvo Group D.G Ltd specializes in the innovation, development, and commercialization of medical devices designed for monitoring pregnancies. Its operations span Israel, the United States, and international markets. The company's key offering is the INVU platform, a remote pregnancy monitoring system that provides expectant mothers with a wearable, self-applied wireless sensor. This technology empowers both the mothers and their obstetricians to track maternal and fetal heart rates, along with maternal uterine activity, conveniently from the comfort of home or within a clinical setting, starting from the 32nd week of gestation until the commencement of labor. The INVU platform itself comprises two main elements: a sophisticated wireless sensor band that utilizes multi-modality technology to capture essential physiological signals, and a complementary cloud-based computing environment. This cloud system is responsible for processing and analyzing the collected data, subsequently generating and delivering customized reports on maternal and fetal health metrics. These insights are then conveyed to the mother and her obstetrician through intuitive digital visualization tools. The company has established strategic partnerships with Royal Philips and Charité – Universitätsmedizin Berlin. Founded in 2006, the firm maintains its headquarters in Tel Aviv, Israel, and was formerly known as Nuvo Group Ltd. before changing its name to Holdco Nuvo Group D.G Ltd in May 2024. Notably, on August 22, 2024, Holdco Nuvo Group D.G Ltd initiated Chapter 11 reorganization proceedings by filing a voluntary petition with the U.S. Bankruptcy Court for the District of Delaware.

Año	Ratio P/E	Cambiar
Not enough data for the provided dates.

Año

Ratio P/E

Cambiar

Not enough data for the provided dates.

Empresa	P/E Ratio	Diferencia del P/E Ratio	País
Abbott Laboratories ABT.US	35.77	-	US
Stryker Corporation SYK.US	34.86	-	US
Medtronic plc MDT.US	21.39	-	IE
Boston Scientific Corporation BSX.US	20.90	-	US
Edwards Lifesciences Corporation EW.US	52.64	-	US

Empresa

P/E Ratio

Diferencia del P/E Ratio

País